June 19, 2020 / 12:34 PM / 23 days ago

BRIEF-Perrigo Divests Its U.K. Generic Prescription Pharmaceuticals Business For About $195 Mln

June 19 (Reuters) - Perrigo Company PLC:

* PERRIGO FURTHERS ITS CONSUMER-FOCUSED TRANSFORMATION BY DIVESTING ITS U.K. GENERIC PRESCRIPTION PHARMACEUTICALS BUSINESS FOR £156 MILLION OR APPROXIMATELY $195 MILLION

* PERRIGO COMPANY - REACHED AGREEMENT TO SELL ITS U.K.-BASED ROSEMONT PHARMACEUTICALS BUSINESS TO A U.K.-HEADQUARTERED PRIVATE EQUITY FIRM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below